The global fetal bovine serum (FBS) market is witnessing steady growth due to increasing utilization of high-quality cell culture supplements in biotechnology, pharmaceutical research, vaccine manufacturing, regenerative medicine, and academic research. Fetal bovine serum provides essential nutrients, growth factors, hormones, and proteins required for optimal cell growth and proliferation in laboratory environments. Rising investments in drug discovery, stem cell research, biologics production, and precision medicine are further supporting market expansion. The market is projected to register a CAGR of 7.2% during the forecast period.
Red biotechnology refers to the application of biotechnological techniques to medical and health-care products and processes. It involves the use of organisms, or their cellular and molecular components, to develop drugs, diagnostics, and genetically modified organisms for therapeutic uses. The sector primarily focuses on the development of vaccines, antibiotics, regenerative therapies, genetic testing, and development of new drug therapies using genetic engineering and molecular biology techniques. The red biotechnology market is projected to grow at a compound annual growth rate (CAGR) of 5.7% over the forecast period.
The cell culture media, sera, and reagents market encompasses a range of products used in the growth, maintenance, and study of cells in vitro. Cell culture media are nutrient-rich solutions designed to support the growth and survival of cells in a laboratory environment. These media can be classified into several types, including serum-free, chemically defined, and protein-free varieties, depending on the specific requirements of the cell type being cultured. Sera, such as fetal bovine serum (FBS), provide a rich source of growth factors and hormones necessary for cell proliferation. Reagents, including supplements and growth factors, are added to the media to aid in cell metabolism, growth regulation, and morphological maintenance. The cell culture media, sera, and reagents market is projected to grow at a compound annual growth rate (CAGR) of 10.5% over the forecast period.
The vinyl sulfone market is expected to grow at a CAGR of 3.5% during the forecast period of 2025 to 2033, driven by key factors reshaping the industry landscape. The industry's growth is propelled by the expanding applications of divinyl sulfone, phenyl vinyl sulfone, and methyl vinyl sulfone, with each type playing a pivotal role at different points in time. The challenges in vinyl sulfone Ester adoption underscore the need for targeted strategies to unlock its full potential.
The metagenomics analysis market highlighting rampant growth at a compounded annual growth rate of 16.9% during the forecast period from 2025 to 2033. Increasing demand for microbial screening in food and chemical industry and significant increase in the bioinformatics segment drive the metagenomic analysis market growth.
The coenzyme A market will showcase impressive growth at a compounded annual growth rate (CAGR) of 8.1% during the forecast period from 2021 to 2029. Coenzyme A is an important biomolecule which has prominent significance in the enzymatic acyl group transfer reactions pertaining to oxidation and synthesis of fatty acids.
The nutrigenomics market is set to reach US$ xx Mn by 2026 from US$ xx Mn in 2017 portraying excellent growth with a compounded annual growth rate (CAGR) of 16.3% during the forecast period from 2018 to 2026. According to the statistics provided by World Health Organization (WHO), by 2020 chronic diseases will be responsible for 73% of the total global deaths associated with obesity, diabetes, cardiovascular complications and cancer.
The global orthobiologics market to reach US$ 9.6 billion in 2029 and projected to exhibit a compound annual growth rate (CAGR) of 5.7% during the forecast period from 2021 to 2029. Orthobiologics are cellular therapy and biologics used to treat or manage certain orthopedic disorders.
Molecular weight markers are commonly known as DNA ladders, RNA ladders or protein ladders. The main function of the molecular weight markers is used for determination and identification of the molecular size of biological samples on gel electrophoresis by using the principle that molecular weight is inversely proportional to migration rate through a gel matrix.
Over the past 100 years cell culture has undergone tremendous evolution from laboratory curiosity into a valuable and widely used research and bio production tool. Earlier researchers used to employ hanging drop cultures or on the bottom of pyrex glass flask and petridishes, which were later replaced with collagen coated plates to improve cell attachment and growth.
The global biotechnology market is anticipated to expand at a CAGR of 15% between 2023 and 2030. Government measures aiming at the modernization of the regulatory environment, improvements in approval processes and reimbursement policies, and standardization of clinical research are driving the market. The expanding influence of personalized medicine and the growing number of orphan drug formulations are creating new opportunities for biotechnology applications, encouraging the emergence of creative biotechnology firms, and enhancing market revenue.
Furthermore, genetically engineered crops and herbicide-tolerant and insect-resistant seeds are gaining popularity and contributing to market expansion. Increasing adoption of tissue culture technology for the production of novel rice variants and disease- and pest-free banana varieties in South Asia and Africa, as well as the use of the technology for the cloning of disease-free and nutrient-rich plant varieties, have propelled agricultural applications for biotechnology. A robust clinical trial pipeline and substantial funding opportunities in tissue engineering and regeneration technologies also drive the industry.
Nanobiotechnology is anticipated to grow at the highest CAGR of 14.8% between 2022 and 2030, due to an increase in nanomedicine approvals and the introduction of advanced technology. For instance, applications of theranostics nanoparticles have gained momentum in order to facilitate quick diagnosis and individualization of therapy choices for several diseases simultaneously. Nanoparticles' low toxicity, smaller size, and chemical adaptability have proven advantageous in overcoming the limitations associated with conventional generic drug administration routes. In addition, tissue engineering and regeneration medicine had a sizable proportion of the market due to government and private expenditures in the field, high healthcare spending, and the existence of numerous mature and emerging competitors in this market.
Acute Market Reports is a market research and strategic consulting company specializing in the biotechnology and healthcare industry. The futuristic research technique offered by Acute Market Reports enables our clients to make timely, well-considered business decisions. We partner with a wide range of industry participants to provide cutting-edge strategic research solutions to our global clients.